Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2019 Nov 12;19(1):280.
doi: 10.1186/s12883-019-1520-2.

The EXPANd trial: effects of exercise and exploring neuroplastic changes in people with Parkinson's disease: a study protocol for a double-blinded randomized controlled trial

Affiliations
Randomized Controlled Trial

The EXPANd trial: effects of exercise and exploring neuroplastic changes in people with Parkinson's disease: a study protocol for a double-blinded randomized controlled trial

Erika Franzén et al. BMC Neurol. .

Abstract

Background: Parkinson's disease (PD) affects many physiological systems essential for balance control. Recent studies suggest that intensive and cognitively demanding physical exercise programs are capable of inducing plastic brain changes in PD. We have developed a highly challenging balance training (the HiBalance) program that emphasizes critical aspects of balance control through progressively introducing more challenging exercises which incorporates dual-tasking. Earlier studies have shown it to be effective in improving balance, gait and dual-tasking. The study design has thereafter been adjusted to link intervention-induced behavioral changes to brain morphology and function. Specifically, in this randomized controlled trial, we will determine the effects of the HiBalance program on balance, gait and cognition and relate this to task-evoked functional MRI (fMRI), as well as brain-derived neurotrophic factor (BDNF) in participants with mild-moderate PD.

Methods: One hundred participants with idiopathic PD, Hoehn & Yahr stage 2 or 3, ≥ 60 years of age, ≥ 21 on Montreal Cognitive Assessment will be recruited in successive waves and randomized into either the HiBalance program or to an active control group (the HiCommunication program, targeting speech and communication). Both interventions will be performed in small groups, twice a week with 1 h sessions for 10 weeks. In addition, a 1 h, once a week, home exercise program will also be performed. A double-blinded design will be used. At the pre- and post-assessments, participants will be assessed on balance (main outcome), gait, cognitive functions, physical activity, voice/speech function, BDNF in serum and fMRI (3 T Philips) during performance of motor-cognitive tasks.

Discussion: Since there is currently no cure for PD, findings of neuroplastic brain changes in response to exercise would revolutionize the way we treat PD, and, in turn, provide new hope to patients for a life with better health, greater independence and improved quality of life.

Trial registration: ClincalTrials.gov: NCT03213873, first posted July 11, 2017.

Keywords: Balance; Cognition; Dual-task; Exercise; Gait; Imaging; Magnetic resonance neural growth factor; Neuroplasticity; Parkinson’s disease.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Flowchart of the study
Fig. 2
Fig. 2
illustrates the experimental set-up of the single tast (ST) and dual-task (DT) during the functional magnetic resonance imaging (fMRI). During both visu-motor tasks four white circles are shown on a black screen with one circle blinking (turning grey) every 1.2 s. The participants will have a 2-button response box in each hand and use their index and middle fingers to respond to the circle turning grey by pressing the corresponding button. During the DT, participants will also perform a counting task, i.e. count how many white plus sign appearing on the screen during the block. After each DT-block, participants will be given four alternatives and respond with the corresponding button how many plus-signs they have counted

References

    1. Schrag A, Jahanshahi M, Quinn N. How does Parkinson's disease affect quality of life? A comparison with quality of life in the general population. Mov Disord. 2000;15(6):1112–1118. doi: 10.1002/1531-8257(200011)15:6<1112::AID-MDS1008>3.0.CO;2-A. - DOI - PubMed
    1. Jankovic J. Parkinson's disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry. 2008;79(4):368–376. doi: 10.1136/jnnp.2007.131045. - DOI - PubMed
    1. Lökk J, Borg S, Svensson J, Persson U, Ljunggren G. Drug and treatment costs in Parkinson's disease patients in Sweden. Acta Neurol Scand. 2012;125(2):142–147. doi: 10.1111/j.1600-0404.2011.01517.x. - DOI - PubMed
    1. Dirnberger G, Jahanshahi M. Executive dysfunction in Parkinson's disease: a review. J Neuropsychol. 2013;7(2):193–224. doi: 10.1111/jnp.12028. - DOI - PubMed
    1. Wu T, Hallett M, Chan P. Motor automaticity in Parkinson's disease. Neurobiol Dis. 2015;82:226–234. doi: 10.1016/j.nbd.2015.06.014. - DOI - PMC - PubMed

Publication types

Associated data